Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Insulet Corp (NASDAQ:PODD)

41.94
Delayed Data
As of Aug 26
 +0.34 / +0.82%
Today’s Change
23.94
Today|||52-Week Range
45.19
+10.92%
Year-to-Date
Moving Average Crossover Alert: Insulet (PODD)
Aug 16 / Zacks.com - Paid Partner Content
Can The Uptrend Continue for Insulet (PODD)?
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.60
Today’s open41.63
Day’s range41.33 - 42.17
Volume482,999
Average volume (3 months)655,452
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-38.71%
Earnings growth (this year)+65.12%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+12.30%
P/E ratioNM
Price/Sales6.62
Price/Book70.15

Competitors

 Today’s
change
Today’s
% change
PENPenumbra Inc+0.89+1.26%
GMEDGlobus Medical Inc+0.14+0.62%
ICUIICU Medical Inc+1.13+0.91%
MASIMasimo Corp+1.09+1.88%
Data as of 4:02pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$324.2M
Annual profit (last year)-$73.5M
Net profit margin-22.68%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO &
Class III Director
Patrick J. Sullivan
Senior VP-Global Manufacturing &
Operations
Charles Alpuche
Corporate headquarters
Billerica, Massachusetts

Forecasts

Partner Offers

Search for Jobs